Bladder cancer

New hope for patients progressing after prior treatment for mUCa

Earn accreditation points

Finish 5 case(s) answer 10 question(s) and Earn 1 credit.

Continue
Освітня мета: Identify appropriate treatment options for patients progressing after prior treatment for metastatic urothelial carcinoma (UCa), a patient population who only had limited options in the past.
Спеціальність: Medical oncology, urology, clinical oncology, (radiation oncology)
Цільова аудиторія: CME (basic, intermediate), Residents (senior)
Останнє оновлення: December 2023
Фон:

Regulatory approval status of drugs limited to the metastatic UCa setting (status 20 December 2023)

CPS: combined positive score